Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS)
CUSIP: 04635X102
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 57,127,897
- Total 13F shares
- 5,732,278
- Share change
- -478,025
- Total reported value
- $17,195,000
- Put/Call ratio
- 0%
- Price per share
- $3.00
- Number of holders
- 25
- Value change
- -$3,741,817
- Number of buys
- 10
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 04635X102?
CUSIP 04635X102 identifies ATXS - Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04635X102:
Top shareholders of ATXS - Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) as of Q2 2022
As of 30 Jun 2022,
Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,732,278 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Ikarian Capital, LLC, VANGUARD GROUP INC, FMR LLC, Cormorant Asset Management, LP, Alyeska Investment Group, L.P., CITADEL ADVISORS LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
29
Q2 2022 holders
25
Holder diff
-4
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.